# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-003616
Filing Date
2022-02-02
Accepted
2022-02-02 16:11:13
Documents
63
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | arwr-10q_20211231.htm iXBRL | 10-Q | 1606851
2 | EX-10.1 | arwr-ex101_514.htm | EX-10.1 | 1143172
3 | EX-10.2 | arwr-ex102_515.htm | EX-10.2 | 382181
4 | EX-10.6 | arwr-ex106_745.htm | EX-10.6 | 70158
5 | EX-31.1 | arwr-ex311_13.htm | EX-31.1 | 9860
6 | EX-31.2 | arwr-ex312_12.htm | EX-31.2 | 10796
7 | EX-32.1 | arwr-ex321_8.htm | EX-32.1 | 6316
8 | EX-32.2 | arwr-ex322_6.htm | EX-32.2 | 6563
| Complete submission text file | 0001564590-22-003616.txt |  | 8500308

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA | arwr-20211231.xsd | EX-101.SCH | 52656
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | arwr-20211231_cal.xml | EX-101.CAL | 45055
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | arwr-20211231_def.xml | EX-101.DEF | 186585
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | arwr-20211231_lab.xml | EX-101.LAB | 402474
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | arwr-20211231_pre.xml | EX-101.PRE | 325329
57 | EXTRACTED XBRL INSTANCE DOCUMENT | arwr-10q_20211231_htm.xml | XML | 1166816

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 22583734
SIC: 2834 Pharmaceutical Preparations